Reference: 666660 · North Rhine-Westphalia · Logistics & transport

Patient transport / medical transport – ASSET DEAL

Company saleReference: 666660
Illustrative image

COMPANY PROFILE

Acquisition opportunity at a glance

A very well-positioned provider in passenger transport, particularly medical and patient transportation, wheelchair transport and related services. The company has operated successfully in its relevant market for decades. It has excellent customer references due to highly personal and individualized patient care.

The company has been established and in demand for decades, with an experienced team in patient and medical transportation for doctor visits, dialysis, hospital stays and similar needs; a modern, impeccably maintained fleet with specialized equipment including wheelchair transport; excellent references based on highly individual and personal patient care; and long-standing reliable relationships with health insurers, social-security institutions and medical facilities.

• The owners are willing to remain available for several months in an advisory and supporting role, with the period negotiable. High need and customer demand ensure strong growth potential in the regional market. The company is to be sold as an ASSET deal for age-related reasons. The transaction includes office equipment, vehicles, health-insurance contracts and employee transfer under Section 613a BGB. Support and induction by the owner, for example under a consulting agreement, can be arranged at the successor’s request.

Key highlights

  • Revenue: €1,188,000
  • Result (metric unspecified): €400,000
  • Employees: 10
Legal notice: Information as supplied in the listing, dated 23 September 2026. Figures, reporting periods, availability and statements in the description must be checked before a transaction. “Result” does not automatically mean EBIT or EBITDA. Illustrative images do not depict the offered company.

CONTROLLED INFORMATION RELEASE

Confidential company information

Enter your contact details, receive the NDA by email and explicitly confirm the NDA and 5% buyer commission in a two-step process.

Request NDA and information